dasatinib

The medicine is used for the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and for the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of CML if previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

The medicine is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of PBSz, in whom previous treatment was not effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

The medicinal product is used in the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents and children (from 1 year of age). It is also used in adults for the blast crisis stage of Ph+ chronic myeloid leukemia in whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

The medicinal product is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children aged 1 year and older. It is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age), and in the lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

Daruph is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia in whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

The medicine is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in the treatment of lymphoblastic blast crisis (PBSz) in adults for whom previous treatment was not effective.

Form: tablets, film-coated

ATC: L01XE06

Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.

Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as to treat lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children from 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children from 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the blast crisis phase of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

This medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in adults in the case of lymphoblastic blast crisis of CML, where previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.

The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in the blast crisis phase of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

It is used in the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in some cases of lymphoblastic blast crisis of CML.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). It is also used in the treatment of blast crisis of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). It is also used in the treatment of blast crisis of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). In adults, it is also used to treat the lymphoblastoid blast crisis phase of CML if previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in the blast crisis phase of CML in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.

Dasatinib Sandoz is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in patients for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (from 1 year of age) for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (over 1 year of age) for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

Dasatinib Stada is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children aged 1 year and older, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicinal product is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the blast crisis phase of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

It is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It helps to inhibit the growth of leukemia cells.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age), as well as to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age), and in a specific form of myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used for the treatment of acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in adults for the lymphoblastoid blast crisis of CML, if previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used for the treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children over 1 year of age, and for the treatment of chronic myeloid leukaemia (CML) in adults, adolescents and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in adults for the lymphoblastoid blast crisis of CML if previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used for the treatment of acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML) in adults, adolescents, and children aged 1 year and older. It inhibits the growth of cancer cells.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia in whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age), as well as in the lymphoblastic blast crisis of myeloid leukemia in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age), as well as to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age), and in the lymphoblastic blast crisis in adults for whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia, in whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia, in whom previous treatment has not been effective.

Form: tablets, film-coated

ATC: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.